COMPASS PATHWAYS PLC (CMPS) Stock News
NASDAQ:CMPS - Nasdaq - US20451W1018 - ADR - Currency: USD
CMPS Latest News, Press Relases and Analysis
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months
Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
Compass Pathways Announces Pricing of Underwritten Offering
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
Don't jump in without doing some research first.
Compass Pathways to Participate in December Investor Conferences
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Compass Pathways to participate in Stifel 2024 Healthcare Conference
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to...
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
CMPS earnings call for the period ending September 30, 2024.
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
Compass Pathways to participate in three investor conferences in September
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to...